Delaware | 000-06920 | 94-1655526 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
3050 Bowers Avenue | ||
P.O. Box 58039 Santa Clara, CA | 95052-8039 | |
(Address of principal executive | (Zip Code) | |
offices) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Exhibit No. | Description | |
99.1 | Press Release issued by Applied Materials, Inc. dated February 12, 2014. |
Applied Materials, Inc. (Registrant) | |||
Date: February 12, 2014 | By: | /s/ Thomas F. Larkins | |
Thomas F. Larkins | |||
Senior Vice President, General Counsel and Corporate Secretary |
Exhibit No. | Description | |
99.1 | Press Release issued by Applied Materials, Inc. dated February 12, 2014. |
• | Net sales and non-GAAP EPS up sequentially and in high end of guidance |
• | Silicon systems net sales up 19% sequentially reflecting strong customer demand for the company’s latest technologies for advanced transistors and NAND memory |
• | Prepares for planned merger with Tokyo Electron |
GAAP Results | Q1 FY2014 | Q4 FY2013 | Q1 FY2013 | |||
Net sales | $2.19 billion | $1.99 billion | $1.57 billion | |||
Operating income | $330 million | $211 million | $39 million | |||
Net income | $253 million | $183 million | $34 million | |||
Diluted earnings per share (EPS) | $0.21 | $0.15 | $0.03 | |||
Non-GAAP Adjusted Results | ||||||
Non-GAAP adjusted operating income | $380 million | $323 million | $112 million | |||
Non-GAAP adjusted net income | $279 million | $228 million | $69 million | |||
Non-GAAP adjusted diluted EPS | $0.23 | $0.19 | $0.06 |
Three Months Ended | ||||||||||||
(In millions, except per share amounts) | January 26, 2014 | October 27, 2013 | January 27, 2013 | |||||||||
Net sales | $ | 2,190 | $ | 1,988 | $ | 1,573 | ||||||
Cost of products sold | 1,299 | 1,193 | 991 | |||||||||
Gross margin | 891 | 795 | 582 | |||||||||
Operating expenses: | ||||||||||||
Research, development and engineering | 356 | 338 | 304 | |||||||||
Marketing and selling | 109 | 99 | 105 | |||||||||
General and administrative | 89 | 117 | 125 | |||||||||
Restructuring charges and asset impairments | 7 | 30 | 9 | |||||||||
Total operating expenses | 561 | 584 | 543 | |||||||||
Income from operations | 330 | 211 | 39 | |||||||||
Impairment of strategic investments | 3 | 1 | — | |||||||||
Interest expense | 25 | 24 | 24 | |||||||||
Interest and other income, net | 13 | 8 | 3 | |||||||||
Income before income taxes | 315 | 194 | 18 | |||||||||
Provision (benefit) for income taxes | 62 | 11 | (16 | ) | ||||||||
Net income | $ | 253 | $ | 183 | $ | 34 | ||||||
Earnings per share: | ||||||||||||
Basic and diluted | $ | 0.21 | $ | 0.15 | $ | 0.03 | ||||||
Weighted average number of shares: | ||||||||||||
Basic | 1,206 | 1,204 | 1,198 | |||||||||
Diluted | 1,225 | 1,222 | 1,212 |
(In millions) | January 26, 2014 | October 27, 2013 | ||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 2,144 | $ | 1,711 | ||||
Short-term investments | 145 | 180 | ||||||
Accounts receivable, net | 1,510 | 1,633 | ||||||
Inventories | 1,533 | 1,413 | ||||||
Other current assets | 682 | 705 | ||||||
Total current assets | 6,014 | 5,642 | ||||||
Long-term investments | 833 | 1,005 | ||||||
Property, plant and equipment, net | 846 | 850 | ||||||
Goodwill | 3,294 | 3,294 | ||||||
Purchased technology and other intangible assets, net | 1,057 | 1,103 | ||||||
Deferred income taxes and other assets | 155 | 149 | ||||||
Total assets | $ | 12,199 | $ | 12,043 | ||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
Current liabilities: | ||||||||
Accounts payable and accrued expenses | $ | 1,576 | $ | 1,649 | ||||
Customer deposits and deferred revenue | 901 | 794 | ||||||
Total current liabilities | 2,477 | 2,443 | ||||||
Long-term debt | 1,946 | 1,946 | ||||||
Other liabilities | 535 | 566 | ||||||
Total liabilities | 4,958 | 4,955 | ||||||
Total stockholders’ equity | 7,241 | 7,088 | ||||||
Total liabilities and stockholders’ equity | $ | 12,199 | $ | 12,043 |
(In millions) | Three Months Ended | ||||||||||
January 26, 2014 | October 27, 2013 | January 27, 2013 | |||||||||
Cash flows from operating activities: | |||||||||||
Net income | $ | 253 | $ | 183 | $ | 34 | |||||
Adjustments required to reconcile net income to cash provided by operating activities: | |||||||||||
Depreciation and amortization | 94 | 98 | 106 | ||||||||
Restructuring charges and asset impairments | 7 | 30 | 9 | ||||||||
Unrealized loss (gain) on derivative associated with announced business combination | (24 | ) | 7 | — | |||||||
Share-based compensation | 46 | 41 | 42 | ||||||||
Other | (16 | ) | 11 | (78 | ) | ||||||
Net change in operating assets and liabilities | 12 | (351 | ) | (97 | ) | ||||||
Cash provided by operating activities | 372 | 19 | 16 | ||||||||
Cash flows from investing activities: | |||||||||||
Capital expenditures | (48 | ) | (50 | ) | (49 | ) | |||||
Proceeds from sales and maturities of investments | 364 | 276 | 445 | ||||||||
Purchases of investments | (163 | ) | (169 | ) | (143 | ) | |||||
Cash provided by investing activities | 153 | 57 | 253 | ||||||||
Cash flows from financing activities: | |||||||||||
Proceeds from common stock issuances and others | 28 | 57 | 18 | ||||||||
Common stock repurchases | — | (47 | ) | (48 | ) | ||||||
Payments of dividends to stockholders | (120 | ) | (120 | ) | (108 | ) | |||||
Cash used in financing activities | (92 | ) | (110 | ) | (138 | ) | |||||
Increase (decrease) in cash and cash equivalents | 433 | (34 | ) | 131 | |||||||
Cash and cash equivalents — beginning of period | 1,711 | 1,745 | 1,392 | ||||||||
Cash and cash equivalents — end of period | $ | 2,144 | $ | 1,711 | $ | 1,523 | |||||
Supplemental cash flow information: | |||||||||||
Cash payments for income taxes | $ | 26 | $ | 12 | $ | 32 | |||||
Cash refunds from income taxes | $ | 9 | $ | 35 | $ | 65 | |||||
Cash payments for interest | $ | 39 | $ | 7 | $ | 39 |
Q1 FY2014 | Q4 FY2013 | Q1 FY2013 | ||||||||||||||||||||||||||||||||||
(In millions) | New Orders | Net Sales | Operating Income (Loss) | New Orders | Net Sales | Operating Income (Loss) | New Orders | Net Sales | Operating Income (Loss) | |||||||||||||||||||||||||||
SSG | $ | 1,569 | $ | 1,484 | $ | 314 | $ | 1,390 | $ | 1,243 | $ | 213 | $ | 1,363 | $ | 969 | $ | 134 | ||||||||||||||||||
AGS | 597 | 507 | 125 | 548 | 538 | 115 | 544 | 471 | 89 | |||||||||||||||||||||||||||
Display | 79 | 159 | 26 | 114 | 163 | 19 | 138 | 87 | 3 | |||||||||||||||||||||||||||
EES | 40 | 40 | (11 | ) | 40 | 44 | (30 | ) | 68 | 46 | (54 | ) | ||||||||||||||||||||||||
Corporate | — | — | (124 | ) | — | — | (106 | ) | — | — | (133 | ) | ||||||||||||||||||||||||
Consolidated | $ | 2,285 | $ | 2,190 | $ | 330 | $ | 2,092 | $ | 1,988 | $ | 211 | $ | 2,113 | $ | 1,573 | $ | 39 |
(In millions) | Q1 FY2014 | Q4 FY2013 | Q1 FY2013 | |||||||||
Restructuring charges and asset impairments | $ | 7 | $ | 23 | $ | 4 | ||||||
Share-based compensation | 46 | 41 | 42 | |||||||||
Other unallocated expenses | 71 | 42 | 87 | |||||||||
Corporate | $ | 124 | $ | 106 | $ | 133 |
Q1 FY2014 | Q4 FY2013 | Q1 FY2013 | ||||||||||||||||
New Orders and Net Sales by Geography | ||||||||||||||||||
(In $ millions) | New Orders | Net Sales | New Orders | Net Sales | New Orders | Net Sales | ||||||||||||
United States | 403 | 280 | 261 | 357 | 391 | 401 | ||||||||||||
% of Total | 18 | % | 13 | % | 12 | % | 18 | % | 19 | % | 25 | % | ||||||
Europe | 119 | 164 | 203 | 242 | 134 | 119 | ||||||||||||
% of Total | 5 | % | 7 | % | 10 | % | 12 | % | 6 | % | 8 | % | ||||||
Japan | 163 | 164 | 117 | 276 | 181 | 98 | ||||||||||||
% of Total | 7 | % | 8 | % | 6 | % | 14 | % | 9 | % | 6 | % | ||||||
Korea | 240 | 201 | 209 | 231 | 198 | 205 | ||||||||||||
% of Total | 11 | % | 9 | % | 10 | % | 12 | % | 9 | % | 13 | % | ||||||
Taiwan | 984 | 705 | 721 | 589 | 906 | 565 | ||||||||||||
% of Total | 43 | % | 32 | % | 34 | % | 30 | % | 43 | % | 36 | % | ||||||
Southeast Asia | 50 | 87 | 95 | 89 | 65 | 58 | ||||||||||||
% of Total | 2 | % | 4 | % | 5 | % | 4 | % | 3 | % | 4 | % | ||||||
China | 326 | 589 | 486 | 204 | 238 | 127 | ||||||||||||
% of Total | 14 | % | 27 | % | 23 | % | 10 | % | 11 | % | 8 | % | ||||||
Employees (In thousands) | ||||||||||||||||||
Regular Full Time | 13.6 | 13.7 | 13.7 |
Three Months Ended | ||||||||||||
(In millions, except percentages and per share amounts) | January 26, 2014 | October 27, 2013 | January 27, 2013 | |||||||||
Non-GAAP Adjusted Gross Margin | ||||||||||||
Reported gross margin - GAAP basis | $ | 891 | $ | 795 | $ | 582 | ||||||
Certain items associated with acquisitions1 | 39 | 40 | 43 | |||||||||
Acquisition integration and deal costs | — | — | 1 | |||||||||
Non-GAAP adjusted gross margin | $ | 930 | $ | 835 | $ | 626 | ||||||
Non-GAAP adjusted gross margin percent (% of net sales) | 42.5 | % | 42.0 | % | 39.8 | % | ||||||
Non-GAAP Adjusted Operating Income | ||||||||||||
Reported operating income - GAAP basis | $ | 330 | $ | 211 | $ | 39 | ||||||
Certain items associated with acquisitions1 | 45 | 47 | 54 | |||||||||
Acquisition integration and deal costs | 11 | 11 | 10 | |||||||||
Unrealized loss (gain) on derivative associated with announced business combination | (24 | ) | 7 | — | ||||||||
Certain items associated with announced business combination2 | 11 | 17 | — | |||||||||
Restructuring charges and asset impairments3, 4, 5 | 7 | 30 | 9 | |||||||||
Non-GAAP adjusted operating income | $ | 380 | $ | 323 | $ | 112 | ||||||
Non-GAAP adjusted operating margin percent (% of net sales) | 17.4 | % | 16.2 | % | 7.1 | % | ||||||
Non-GAAP Adjusted Net Income | ||||||||||||
Reported net income - GAAP basis | $ | 253 | $ | 183 | $ | 34 | ||||||
Certain items associated with acquisitions1 | 45 | 47 | 54 | |||||||||
Acquisition integration and deal costs | 11 | 11 | 10 | |||||||||
Unrealized loss (gain) on derivative associated with announced business combination | (24 | ) | 7 | — | ||||||||
Certain items associated with announced business combination2 | 11 | 17 | — | |||||||||
Restructuring charges and asset impairments3, 4, 5 | 7 | 30 | 9 | |||||||||
Impairment (gain on sale) of strategic investments, net | (5 | ) | (3 | ) | — | |||||||
Reinstatement of federal R&D tax credit | — | — | (10 | ) | ||||||||
Resolution of prior years’ income tax filings and other tax items | (15 | ) | (10 | ) | (11 | ) | ||||||
Income tax effect of non-GAAP adjustments | (4 | ) | (54 | ) | (17 | ) | ||||||
Non-GAAP adjusted net income | $ | 279 | $ | 228 | $ | 69 |
1 | These items are incremental charges attributable to completed acquisitions, consisting of inventory fair value adjustments on products sold, and amortization of purchased intangible assets. |
2 | These items are incremental charges related to the announced business combination agreement with Tokyo Electron Limited, consisting of acquisition-related and integration costs. |
3 | Results for the three months ended January 26, 2014 included employee-related costs of $7 million related to the restructuring program announced on October 3, 2012. |
4 | Results for the three months ended October 27, 2013 included $27 million of employee-related costs related to the restructuring program announced on October 3, 2012, and restructuring and asset impairment charges of $7 million related to the restructuring program announced on May 10, 2012, partially offset by a favorable adjustment of $4 million in restructuring charges related to other restructuring plans. |
5 | Results for the three months ended January 27, 2013 included $4 million of employee-related costs related to the restructuring program announced on October 3, 2012, asset impairment charges of $3 million related to the restructuring program announced on May 10, 2012 and severance charges of $2 million related to the integration of Varian. |
Three Months Ended | ||||||||||||
(In millions except per share amounts) | January 26, 2014 | October 27, 2013 | January 27, 2013 | |||||||||
Non-GAAP Adjusted Earnings Per Diluted Share | ||||||||||||
Reported earnings per diluted share - GAAP basis | $ | 0.21 | $ | 0.15 | $ | 0.03 | ||||||
Certain items associated with acquisitions | 0.03 | 0.03 | 0.03 | |||||||||
Acquisition integration and deal costs | 0.01 | — | 0.01 | |||||||||
Unrealized gain on derivative associated with announced business combination | (0.01 | ) | — | — | ||||||||
Certain items associated with announced business combination | — | 0.01 | — | |||||||||
Restructuring charges and asset impairments | — | 0.01 | 0.01 | |||||||||
Reinstatement of federal R&D tax credit and resolution of prior years’ income tax filings and other tax items | (0.01 | ) | (0.01 | ) | (0.02 | ) | ||||||
Non-GAAP adjusted earnings per diluted share | $ | 0.23 | $ | 0.19 | $ | 0.06 | ||||||
Weighted average number of diluted shares | 1,225 | 1,222 | 1,212 |
Three Months Ended | ||||||||||||
(In millions, except percentages) | January 26, 2014 | October 27, 2013 | January 27, 2013 | |||||||||
SSG Non-GAAP Adjusted Operating Income | ||||||||||||
Reported operating income - GAAP basis | $ | 314 | $ | 213 | $ | 134 | ||||||
Certain items associated with acquisitions1 | 42 | 44 | 44 | |||||||||
Acquisition integration and deal costs, net | 1 | 1 | 1 | |||||||||
Restructuring charges and asset impairments3 | — | — | 1 | |||||||||
Non-GAAP adjusted operating income | $ | 357 | $ | 258 | $ | 180 | ||||||
Non-GAAP adjusted operating margin percent (% of net sales) | 24.1 | % | 20.8 | % | 18.6 | % | ||||||
AGS Non-GAAP Adjusted Operating Income | ||||||||||||
Reported operating income - GAAP basis | $ | 125 | $ | 115 | $ | 89 | ||||||
Certain items associated with acquisitions1 | 1 | 1 | 1 | |||||||||
Restructuring charges and asset impairments3 | — | — | 1 | |||||||||
Non-GAAP adjusted operating income | $ | 126 | $ | 116 | $ | 91 | ||||||
Non-GAAP adjusted operating margin percent (% of net sales) | 24.9 | % | 21.6 | % | 19.3 | % | ||||||
Display Non-GAAP Adjusted Operating Income | ||||||||||||
Reported operating income - GAAP basis | $ | 26 | $ | 19 | $ | 3 | ||||||
Certain items associated with acquisitions1 | 1 | 1 | 2 | |||||||||
Non-GAAP adjusted operating income | $ | 27 | $ | 20 | $ | 5 | ||||||
Non-GAAP adjusted operating margin percent (% of net sales) | 17.0 | % | 12.3 | % | 5.7 | % | ||||||
EES Non-GAAP Adjusted Operating Loss | ||||||||||||
Reported operating loss - GAAP basis | $ | (11 | ) | $ | (30 | ) | $ | (54 | ) | |||
Certain items associated with acquisitions1 | 1 | 1 | 7 | |||||||||
Restructuring charges and asset impairments2, 3 | — | 7 | 3 | |||||||||
Non-GAAP adjusted operating loss | $ | (10 | ) | $ | (22 | ) | $ | (44 | ) | |||
Non-GAAP adjusted operating margin percent (% of net sales) | (25.0 | )% | (50.0 | )% | (95.7 | )% |
1 | These items are incremental charges attributable to completed acquisitions, consisting of inventory fair value adjustments on products sold, and amortization of purchased intangible assets. |
2 | Results for the three months ended October 27, 2013 included restructuring and asset impairment charges of $7 million related to the restructuring program announced on May 10, 2012. |
3 | Results for the three months ended January 27, 2013 included asset impairment charges of $3 million related to the restructuring program announced on May 10, 2012 and severance charges of $2 million related to the integration of Varian. |
Three Months Ended | |||||||
(In millions) | January 26, 2014 | October 27, 2013 | |||||
Operating expenses - GAAP basis | $ | 561 | $ | 584 | |||
Unrealized gain (loss) on derivative associated with announced business combination | 24 | (7 | ) | ||||
Restructuring charges and asset impairments | (7 | ) | (30 | ) | |||
Certain items associated with acquisitions | (6 | ) | (7 | ) | |||
Acquisition integration costs | (11 | ) | (11 | ) | |||
Certain items associated with announced business combination | (11 | ) | (17 | ) | |||
Non-GAAP adjusted operating expenses | $ | 550 | $ | 512 |
Three Months Ended | |||
(In millions, except percentages) | January 26, 2014 | ||
Provision for income taxes - GAAP basis (a) | $ | 62 | |
Resolutions of prior years’ income tax filings and other tax items | 15 | ||
Income tax effect of non-GAAP adjustments | 4 | ||
Non-GAAP adjusted provision for income taxes (b) | $ | 81 | |
Income before income taxes - GAAP basis (c) | $ | 315 | |
Certain items associated with acquisitions | 45 | ||
Restructuring charges and asset impairments | 7 | ||
Acquisition integration costs | 11 | ||
Unrealized gain on derivative associated with announced business combination | (24 | ) | |
Certain items associated with announced business combination | 11 | ||
Gain on sale strategic investments, net | (5 | ) | |
Non-GAAP adjusted income before income taxes (d) | $ | 360 | |
Effective income tax rate - GAAP basis (a/c) | 19.7 | % | |
Non-GAAP adjusted effective income tax rate (b/d) | 22.5 | % |